HCPCS Level IIdrugActive
J3245
Inj., tildrakizumab, 1 mg
BETOS: O1E
Effective: 2019-01-01
Description
Injection, tildrakizumab, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Ilumya
Manufacturer
Sun Pharmaceutical Global FZE.
HCPCS Dosage
1 MG
Billing Units
100.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.